STAT June 21, 2024
ORLANDO — The United States is at a critical juncture in its efforts to treat chronic diseases, particularly type 2 diabetes, and now has a chance to change the dangerous trajectory it’s currently following, FDA Commissioner Robert Califf said Friday.
“The U.S. is leading the world in technology development, innovation, new gadgets of all kinds, new drugs, you name it,” he said. “These advantages unfortunately are not resulting in superior health and outcomes for the U.S., population, or for most individuals in the U.S.”
Health outcomes as a whole are deteriorating in the U.S., Califf said in his remarks at the American Diabetes Association conference, but he sees one outlier.
“There’s an exception for type 1 diabetes, which I believe...
Today's Sponsors
Today's Sponsor